Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bordeaux

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 16, 2019
Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic SyndromesWade T Iams, Eileen Shiuan, Catherine B Meador, et al.
Science Signaling|September 4, 2008
Linear motif atlas for phosphorylation-dependent signalingMartin Lee Miller, Lars Juhl Jensen, Francesca Diella, et al.
JCI Insight|July 8, 2020
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBCDerek A Franklin, Joe T Sharick, Paula I Ericsson-Gonzalez, et al.
JCI Insight|December 21, 2018
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagementDouglas B Johnson, Mellissa J Nixon, Yu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced MelanomaYana G Najjar, Dustin McCurry, Huang Lin, et al.
Cancers|April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 16, 2019
Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic SyndromesWade T Iams, Eileen Shiuan, Catherine B Meador, et al.
Science Signaling|September 4, 2008
Linear motif atlas for phosphorylation-dependent signalingMartin Lee Miller, Lars Juhl Jensen, Francesca Diella, et al.
JCI Insight|July 8, 2020
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBCDerek A Franklin, Joe T Sharick, Paula I Ericsson-Gonzalez, et al.
JCI Insight|December 21, 2018
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagementDouglas B Johnson, Mellissa J Nixon, Yu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced MelanomaYana G Najjar, Dustin McCurry, Huang Lin, et al.
Cancers|April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Pageof 2